Amneal Pharmaceuticals, Inc.

Q2 2018 13F Holders

Symbol
AMRX
CUSIP
03168L105
Type
Equity
Class
COM STK CL A
Num filings
170
Total reported value, excl. options
$1.60 B
Manager Report Date Value ($000) Shares Option Type